Hyperbaric oxygen therapy can expedite the healing of certain types of chronic, non-healing wounds, such as diabetic wounds, as well as reduce patient suffering, disability and prevent unnecessary hospitalizations and amputations.
Hyperbaric Oxygen Therapy (HBOT) is recognized by Health Canada, all provincial Ministries of Health and internationally for of the following conditions:
- Decompression sickness
- Air or gas embolus
- Arterial Insufficiencies:
- Selected Problem Wounds
- Central Retinal Artery Occlusion
- Selected Problem Wounds
- Osteomyelitis (bone infections)
- Delayed Radiation Injuries
- Compromised grafts and flaps
- Sudden hearing loss
- Crush injuries
- Acute thermal burns
- Carbon monoxide poisoning
- Gas gangrene
- Necrotizing soft tissue infections
- Severe anemia
- Intracranial abscess
Hyperbaric Oxygen: How it works
Hyperbaric oxygen saturates the patient’s blood with oxygen. Once hemoglobin in red blood cells become fully saturated with oxygen, serum becomes saturated. Oxygen saturated serum can support life, even in the absence of hemoglobin while the patient is in a hyperbaric chamber. Patients with severe anemia (blood loss) can be successfully kept alive in a hyperbaric chamber until matched blood becomes available.
In tissues that have poor circulation, ischemia (lack of blood) and/or hypoxia (lack of oxygen), the macrophages (cells that fight infection) and fibroblasts (cells responsible for wound healing) cannot function. Wounds can deteriorate and ultimately result in limb amputation. Hyperbaric oxygen can arrest and reverse this situation by causing angiogenesis, the growth of new blood vessels, as shown in the following macro-photograph of a healing wound.
Hyperbaric oxygen increases the release of nitric oxide, which in turn causes the release of stem cells, which differentiate into blood vessels, skin and nerve cells. A single hyperbaric treatment can double the amount of circulating stem cells. After twenty or more hyperbaric treatments, stem cells can be increased eightfold.
Hyperbaric oxygen also caused the release of growth factors in the blood including:
- Vascular Endothelial Growth Factor (VEGF)- binds to blood vessel walls causing new blood vessels growth
- Platelet Derived Growth Factor (PDGF) – regulates cell growth, division and angiogenesis
- Matrix Metallo-Proteinase (MMP- 2 & 9) – increases tissue remodelling and angiogenesis
- Tissue Inhibitor of Metallo- Proteinase (TIMP-1) – promotes cell proliferation
In addition, hyperbaric oxygen is:
- Bactericidal/static (kills/suppresses) many of the bacteria responsible for wound infections, including those bacteria responsible for gas gangrene and necrotising fasciitis (flesh eating disease)
- Decreases the ischemia/Reperfusion injury often seen in crush injuries
- Decreases the lipid peroxidation injury in carbon monoxide poisoning which can result in irreversible brain damage.
- Saves failing skin grafts and flaps
Topical oxygen therapy is not hyperbaric therapy and the two treatments should not be confused. Linden R, Ledez K, Hopf H, Fife C. Int Wound J. 2014 Apr;11(2):230-1. doi: 10.1111/j.1742-481X.2012.01069.x. Epub 2012 Aug 22.PMID: 22913614